These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 343907)

  • 61. Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG).
    Hauschild A; Garbe C; Stolz W; Ellwanger U; Seiter S; Dummer R; Ugurel S; Sebastian G; Nashan D; Linse R; Achtelik W; Mohr P; Kaufmann R; Fey M; Ulrich J; Tilgen W
    Br J Cancer; 2001 Apr; 84(8):1036-42. PubMed ID: 11308250
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dacarbazine combined targeted therapy versus dacarbazine alone in patients with malignant melanoma: a meta-analysis.
    Jiang G; Li RH; Sun C; Liu YQ; Zheng JN
    PLoS One; 2014; 9(12):e111920. PubMed ID: 25502446
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Cytostatic chemotherapy of lymphogranulomatosis].
    Dold U
    Dtsch Med Wochenschr; 1978 Feb; 103(6):235-8. PubMed ID: 75085
    [No Abstract]   [Full Text] [Related]  

  • 64. [Chemotherapy in advanced malignant melanoma. Results of a controlled trial comparing a combination of dacarbazine (DTIC) and detorubicin with dacarbazine alone].
    Chauvergne J; Bui NB; Cappelaere P; Gary-Bobo J; Guerrin J; Armand JP; Durand M
    Sem Hop; 1982 Dec; 58(46):2697-701. PubMed ID: 6297068
    [TBL] [Abstract][Full Text] [Related]  

  • 65. cis-Dichlorodiammineplatinum(II) and DTIC in malignant melanoma.
    Karakousis CP; Getaz EP; Bjornsson S; Henderson ES; Irequi M; Martinez L; Ospina J; Cavins J; Preisler H; Holyoke E; Holtermann O
    Cancer Treat Rep; 1979; 63(11-12):2009-10. PubMed ID: 393386
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical trials of chemotherapy and chemoimmunotherapy in primary malignant melanoma.
    Jacquillat C; Banzet P; Maral J
    Recent Results Cancer Res; 1982; 80():254-8. PubMed ID: 7036288
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [DTIC--one component of ABVD combination therapy in Hodgkin's disease (author's transl)].
    Lutz D; Waldner R; Höcker P; Baumgartner G
    Wien Klin Wochenschr; 1978 Dec; 90(24):876-7. PubMed ID: 741755
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma.
    Legha SS; Ring S; Papadopoulos N; Plager C; Chawla S; Benjamin R
    Cancer; 1989 Nov; 64(10):2024-9. PubMed ID: 2804890
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of combination adriamycin (NSC-123127) and DTIC (NSC-45388) in children with advanced stage IV neuroblastoma.
    Leikin S; Bernstein I; Evans A; Finklestein J; Hittle R; Klemperer M
    Cancer Chemother Rep; 1975; 59(5):1015-8. PubMed ID: 1106842
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combination chemotherapy with ifosfamide and cis-dichlorodiammineplatinum (II) in advanced malignant melanoma.
    Becher R; Seeber S; Schmidt CG
    J Cancer Res Clin Oncol; 1980; 97(3):301-6. PubMed ID: 7192287
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanoma.
    Robidoux A; Gutterman JU; Bodey GP; Hersh EM
    Cancer; 1982 Jun; 49(11):2246-51. PubMed ID: 7042068
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF; Eagan RT; Edmonson JH
    Cancer Chemother Rep; 1975; 59(2 Pt 1):451-3. PubMed ID: 1097102
    [No Abstract]   [Full Text] [Related]  

  • 73. Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma.
    Lee SM; Margison GP; Woodcock AA; Thatcher N
    Br J Cancer; 1993 Jun; 67(6):1356-60. PubMed ID: 8512821
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combination chemotherapy for disseminated malignant melanoma.
    Costanzi JJ; Vaitkevicius VK; Quagliana JM; Hoogstraten B; Coltman CA; Delaney FC
    Cancer; 1975 Feb; 35(2):342-6. PubMed ID: 1111912
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A retrospective study of biochemotherapy for metastatic melanoma: the importance of dose intensity.
    Minor DR; Madland MT; Kashani-Sabet M; Denny SR; Harvey WB
    Cancer Biother Radiopharm; 2005 Oct; 20(5):479-86. PubMed ID: 16248763
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma.
    Newlands ES; Oon CJ; Roberts JT; Elliott P; Mould RF; Topham C; Madden FJ; Newton KA; Westbury G
    Br J Cancer; 1976 Aug; 34(2):174-9. PubMed ID: 962994
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dacarbazine (DTIC) in malignant melanoma.
    Drug Ther Bull; 1976 May; 14(10):39-40. PubMed ID: 976088
    [No Abstract]   [Full Text] [Related]  

  • 78. [Treatment of advanced malignant melanoma with DTIC].
    Jassem J; Kopacz A; Wojszwiłło-Geppert E
    Pol Tyg Lek; 1979 Feb; 34(8):293-5. PubMed ID: 441041
    [No Abstract]   [Full Text] [Related]  

  • 79. Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).
    Baker LH; Frank J; Fine G; Balcerzak SP; Stephens RL; Stuckey WJ; Rivkin S; Saiki J; Ward JH
    J Clin Oncol; 1987 Jun; 5(6):851-61. PubMed ID: 3295129
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Treatment of malignant melanoma with DTIC--therapeutic effects determined by 5-S-cysteinyldopa changes in the urine (proceedings)].
    Agrup G; Hafström L; Jönsson PE; Rorsman H
    Lakartidningen; 1978 Dec; 75(49):4599-600. PubMed ID: 364213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.